LH - Laboratory Corp of America Holdings - SEC Form 4 Insider Trading Screener

Services - Health Services - Medical Laboratories - LH (920148)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
30 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
S22+0+1+2+13

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

D
2017-09-06
LHKing David PPres, CEOS - Sale+OE$156.86-44,687255,723-15%-$7,009,784
D
2017-09-05
LHKing David PPres, CEOS - Sale+OE$157.06-132,713255,723-34%-$20,843,373
D
2017-08-25
LHEberts F Samuel IIIGC, SecretaryS - Sale+OE$155.22-31,50023,694-57%-$4,889,471
D
2017-08-11
LHWilliams R SandersDirS - Sale+OE$156.88-3,1006,973-31%-$486,338
2017-08-01
LHDodson Edward TPrincipal Accounting OfficerS - Sale$160.13-2,8715,031-36%-$459,739
2017-08-01
LHUthgenannt Lisa JCHROS - Sale$160.00-5,0003,622-58%-$800,000
2017-08-01
LHEisenberg Glenn ACFO, EVPS - Sale$159.46-5,96818,122-25%-$951,672
2017-05-22
LHBerberian LanceSVP, CIOS - Sale$139.84-3,6135,789-38%-$505,259
D
2017-05-09
LHBelingard Jean-LucDirS - Sale+OE$142.19-99231,943-3%-$141,0520
2017-03-09
LHEisenberg Glenn ACFO, EVPS - Sale$142.47-2,30010,356-18%-$327,690000
D
2017-02-24
LHMittelstaedt Robert E JrDirS - Sale+OE$142.69-5,30012,908-29%-$756,258000
D
2017-02-23
LHAnderson Kerrii BDirS - Sale+OE$140.00-1,99216,832-11%-$278,880000
2016-08-09
LHUthgenannt Lisa JCHROS - Sale$140.00-1,1773,660-24%-$164,780+1-1-4-5
2016-08-04
LHEisenberg Glenn ACFO, EVPS - Sale$140.10-8,0008,268-49%-$1,120,804-1-1-2-8
D
2016-08-04
LHMittelstaedt Robert E JrDirS - Sale+OE$140.15-99211,348-8%-$139,027-1-1-2-8
D
2016-06-13
LHKing David PPres, CEOS - Sale+OE$128.00-196,400190,800-51%-$25,139,148+1+1+8+2
2016-04-29
LHUthgenannt Lisa JCHROS - Sale$125.17-3,7404,837-44%-$468,1360-1+1-4
2016-04-27
LHDodson Edward TPrincipal Accounting OfficerS - Sale$126.42-9,3922,717-78%-$1,187,3370-1+2+1
2016-03-31
LHEberts F Samuel IIIGC, SecretaryS - Sale$116.85-4,21918,066-19%-$492,990+1+1+7+17
2016-03-31
LHBoyle James T. Jr.EVP,CEO of LabCorp DiagnosticsS - Sale$116.81-18,13223,454-44%-$2,118,030+1+1+7+17
D
2016-03-14
LHEberts F Samuel IIIGC, SecretaryS - Sale+OE$115.32-30918,066-2%-$35,634-2-1+3+19
D
2016-03-14
LHBoyle James T. Jr.EVP,CEO of LabCorp DiagnosticsS - Sale+OE$115.32-1,54323,454-6%-$177,939-2-1+3+19
D
2016-02-25
LHBelingard Jean-LucDirS - Sale+OE$109.74-1,29629,426-4%-$142,225-1+1+4+22
2016-02-16
LHBoyle James T. Jr.EVP,CEO of LabCorp DiagnosticsS - Sale$103.02-4,05523,454-15%-$417,746+3+4+6+31
2016-02-16
LHEberts F Samuel IIIGC, SecretaryS - Sale$103.02-37018,066-2%-$38,117+3+4+6+31
D
2016-02-12
LHBoyle James T. Jr.EVP,CEO of LabCorp DiagnosticsS - Sale+OE$101.67-2,71227,509-9%-$275,729+1+6+8+35
D
2016-02-12
LHEberts F Samuel IIIGC, SecretaryS - Sale+OE$101.67-40518,436-2%-$41,176+1+6+8+35
2016-01-08
LHEberts F Samuel IIIGC, SecretaryS - Sale$119.05-1,21518,066-6%-$144,646-3-4-9+18
2015-12-08
LHEberts F Samuel IIIGC, SecretaryS - Sale$123.31-1,01019,281-5%-$124,543-10-6+6
D
2015-11-02
LHWilliams R SandersDirS - Sale+OE$124.30-1,8504,176-31%-$229,949-10-20

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top